Data and Safety Monitoring Board Approves LyGenesis’s Phase 2a Clinical Trial to Continue and Dose Escalate in Novel Trial of Organ Regeneration
The next four patients will receive a higher dose of LyGenesis's cell therapy to grow functioning liver tissue in patients with end stage liver disease.
Hevolution Foundation
Our co-founder Dr. Greg Bailey took to the stage in Riyadh at Hevolution Foundation hashtag#GHS2025 with fellow investment leaders.
WHX Dubai
Reflecting on an inspiring & productive week at WHX Dubai - with the latest & best in healthcare innovation.
Buck Institute for Research on Aging
This week, four members of the Juvenescence® team—Kersten Small, Jeff Madwed, Steve Felstead, and myself—had the privilege of visiting the Buck Institute for Research on Aging.
Morphoceuticals
Listen in to Prof Michael Levin & Prof David Kaplan discussing the Morphoceuticals vision and groundbreaking approach of mapping & manipulating the bioelectrome to induce regeneration.
The Longevity Forum
Bridging science and society to help achieve longer, healthier and more fulfilled lives for as many people as possible.
Accelerated hit identification with target evaluation, deep learning and automated labs: prospective validation in IRAK1
Abstract Background Target identification and hit identification can be transformed through the application of biomedical knowledge analysis, AI-driven virtual screening and robotic […]
Biomarkers of Aging Consortium
I had the best time attending the 2024 Biomarkers of Aging Consortium Conference at Harvard Medical School !
First day at the The Longevity Forum in London
A fantastic first day at the The Longevity Forum in London, filled with valuable insights.
SE(3) Equivariant Topologies for Structure-based Drug Discovery
Abstract Modeling protein-ligand interactions is a challenging task that has been approached through an array of perspectives. From physics-based computational approaches to […]
HydraScreen: A Generalizable Structure-Based Deep Learning Approach to Drug Discovery
We propose HydraScreen, a deep-learning framework for safe and robust accelerated drug discovery. HydraScreen utilizes a state-of-the-art 3D convolutional neural network designed […]